(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid

560-53-2

CAS-Nr.: 560-53-2

Bezeichnung:: (3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid

Englisch Name:: K-strophanthin-beta

Synonyma:: Nsc4320;STROPHANTHIN;K-strophanthin-beta;.beta.-K-Strophanthin;Strophanthin K (crystalline);.beta.-Strophanthobioside, strophanthidin-3;3β-[(4-O-β-D-Glucopyranosyl-3-O-methyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide;(3β,5β)-3-{[2,6-dideoxy-4-O-(β-D-glucopyranosyl)-3-O-methyl-β-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide;Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-xylo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-;5.beta.-Card-20(22)-enolide, 3.beta.-[(2,6-dideoxy-4-o-.beta.-D-glucopyranosyl-3-o-methyl-.beta.-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-

CBNumber:: CB72130870

Summenformel:: C36H54O14

Molgewicht:: 710.81

MOL-Datei:: 560-53-2.mol

Request For Quotation

Eigenschaften Sicherheit Verwendungswort

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Eigenschaften

Schmelzpunkt:: 195°C

Siedepunkt:: 628.39°C (rough estimate)

Dichte: 1.1625 (rough estimate)

Brechungsindex: 1.6130 (estimate)

pka: 12.89±0.70(Predicted)

Sicherheit

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Strophanthin is made up of a mixture of glycosides, mainly K-strophanthin- β, 3β,5,14-trihydroxy-10-oxo-5β-card-20(22)-enolide-3-D-cymaro-β-D-glycoside, and K-strophanthoside, 3β,5,14-trihydroxy-10-oxo-5β-card-20(22)-enolide-3-Dcymaro- β-D-gluco-α-D-glycozide. It is isolated primarily from the family Strophantus kombe.

Verwenden

Strophanthin is used in severe cardiovascular insufficiency, in particular after myocardial infarction, for chronic cardiac insufficiency, cardiac decompensation, supraventricular tachycardia, and ventricular arrhythmia.

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 0)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate

560-53-2((3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid)Verwandte Suche:

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid 5β,14-Dihydroxy-19-oxocard-20(22)enolid-3β-acetat 3-((O-beta-D-Glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl-(1-4)-2,6-dideoxy-3-O-methyl-beta-D-ribo-he-xopyranosyl)oxy)-5,14-dihydroxy-19-oxocard-2O(22)-enolid, (3 beta,5 beta)- 3-((2,6-Didesoxy-beta-D-ribo-hexo-pyranosyl)oxy)-5,14-dihydroxy-19-oxo-card-20(22)-enolid,(3 beta, 5 beta)- Convallatoxin (3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid K-Strophantin Cymarin

STROPHANTHIN
K-strophanthin-beta
3β-[(4-O-β-D-Glucopyranosyl-3-O-methyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide
.beta.-K-Strophanthin
.beta.-Strophanthobioside, strophanthidin-3
5.beta.-Card-20(22)-enolide, 3.beta.-[(2,6-dideoxy-4-o-.beta.-D-glucopyranosyl-3-o-methyl-.beta.-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-
Card-20(22)-enolide, 3-[(2,6-dideoxy-4-o-.beta.-D-glucopyranosyl-3-o-methyl-.beta.-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3.beta.,5.beta.)-
Nsc4320
Strophanthin K (crystalline)
(3β,5β)-3-{[2,6-dideoxy-4-O-(β-D-glucopyranosyl)-3-O-methyl-β-D-ribo-hexopyranosyl]oxy}-5,14-dihydroxy-19-oxocard-20(22)-enolide
Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-xylo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
560-53-2